ESC 365 - Device therapy in patients with congenital heart disease: evidence and clinical practice.

EHRA Premium Access

Device therapy in patients with congenital heart disease: evidence and clinical practice.

Session: Ablation and device therapy in patients with congenital heart disease

Topic: Congenital Heart Disease and Paediatric Cardiology

Speaker: Professor J. Janousek (Prague, CZ)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Professor Jan Janousek

Motol University Hospital, Prague (Czechia)

5 presentations

0 follower

4 more presentations in this session

Risk stratification in patients with repaired tetralogy of Fallot: role of imaging and electrophysiology study.

Speaker: Professor K. Wasmer (Bremen, DE)

Ablation of ventricular tachycardia in patients with repaired tetralogy of Fallot.

Speaker: Professor K. Zeppenfeld (Leiden, NL)

Common surgical corrections in congenital heart disease: techniques and implications for ablation therapy.

Speaker: Professor M. Hazekamp (NL)

Ablation and device therapy in patients with congenital heart disease - discussion.

Access the full session

Ablation and device therapy in patients with congenital heart disease

Speakers: Professor J. Janousek, Professor K. Wasmer, Professor K. Zeppenfeld, Professor M. Hazekamp

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources